The HIV-1 transmission bottleneck

[1]  A. Trkola,et al.  Reply to correspondence ‘Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a “stochastic” process’ by Gonzalez et al., Retrovirology 2017 , 2017, Retrovirology.

[2]  J. Spouge,et al.  Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a “stochastic” process , 2017, Retrovirology.

[3]  G. Learn,et al.  Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness , 2017, Proceedings of the National Academy of Sciences.

[4]  Jace W. Jones,et al.  Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy , 2016, Science.

[5]  A. Trkola,et al.  Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs , 2016, Retrovirology.

[6]  F. Kirchhoff,et al.  Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance , 2016, mBio.

[7]  J. Kohlmeier,et al.  Progesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential , 2016, The Journal of Immunology.

[8]  Sergei L. Kosakovsky Pond,et al.  Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus , 2016, PLoS pathogens.

[9]  Yan Wang,et al.  The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection , 2016, Virologica Sinica.

[10]  H. Jaspan,et al.  Genital inflammation, immune activation and risk of sexual HIV acquisition , 2016, Current opinion in HIV and AIDS.

[11]  M. Lederman,et al.  Prevention of SHIV transmission by topical IFN-β treatment , 2015, Mucosal Immunology.

[12]  Martin J. Deymier,et al.  Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance , 2015, PLoS pathogens.

[13]  Shuntai Zhou,et al.  R5 Macrophage-Tropic HIV-1 in the Male Genital Tract , 2015, Journal of Virology.

[14]  S. Karim,et al.  South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication , 2015, Retrovirology.

[15]  R. Swanstrom,et al.  Bottlenecks in HIV-1 transmission: insights from the study of founder viruses , 2015, Nature Reviews Microbiology.

[16]  R. Swanstrom,et al.  Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS , 2015, Current HIV/AIDS Reports.

[17]  D. Lauffenburger,et al.  Genital inflammation and the risk of HIV acquisition in women. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  T. Hope,et al.  Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues , 2015, Journal of Virology.

[19]  Gianguido C. Cianci,et al.  Visualization of HIV-1 Interactions with Penile and Foreskin Epithelia: Clues for Female-to-Male HIV Transmission , 2015, PLoS pathogens.

[20]  N. Dejucq-Rainsford,et al.  Origins of HIV-infected leukocytes and virions in semen. , 2014, The Journal of infectious diseases.

[21]  M. Brameier,et al.  Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection , 2014, Nature Medicine.

[22]  S. Zolla-Pazner,et al.  Brief Definitive Report , 2022 .

[23]  T. Hope,et al.  Vaginal Challenge with an SIV-Based Dual Reporter System Reveals That Infection Can Occur throughout the Upper and Lower Female Reproductive Tract , 2014, PLoS pathogens.

[24]  R. Gottardo,et al.  The Inner Foreskin of Healthy Males at Risk of HIV Infection Harbors Epithelial CD4+ CCR5+ Cells and Has Features of an Inflamed Epidermal Barrier , 2014, PloS one.

[25]  J. Nie,et al.  Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12 , 2014, Virologica Sinica.

[26]  Jerome H. Kim,et al.  Impact of Clade, Geography, and Age of the Epidemic on HIV-1 Neutralization by Antibodies , 2014, Journal of Virology.

[27]  Hua-Xin Liao,et al.  Envelope Glycoprotein Binding to the Integrin α4β7 Is Not a General Property of Most HIV-1 Strains , 2014, Journal of Virology.

[28]  D. Richman,et al.  HIV migration between blood and cerebrospinal fluid or semen over time. , 2014, The Journal of infectious diseases.

[29]  M. Lewinski,et al.  Activities of Transmitted/Founder and Chronic Clade B HIV-1 Vpu and a C-Terminal Polymorphism Specifically Affecting Virion Release , 2014, Journal of Virology.

[30]  W. Greene,et al.  Enhanced Fusion and Virion Incorporation for HIV-1 Subtype C Envelope Glycoproteins with Compact V1/V2 Domains , 2013, Journal of Virology.

[31]  J. Hoxie,et al.  Quantification of Entry Phenotypes of Macrophage-Tropic HIV-1 across a Wide Range of CD4 Densities , 2013, Journal of Virology.

[32]  H. Ding,et al.  Relative resistance of HIV-1 founder viruses to control by interferon-alpha , 2013, Retrovirology.

[33]  Jessica Prince,et al.  Selection bias at the heterosexual HIV-1 transmission bottleneck , 2013, Science.

[34]  M. Sagar,et al.  Early Infection HIV-1 Envelope V1-V2 Genotypes Do Not Enhance Binding or Replication in Cells Expressing High Levels of &agr;4&bgr;7 Integrin , 2013, Journal of acquired immune deficiency syndromes.

[35]  M. Nussenzweig,et al.  Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia , 2013, Nature.

[36]  L. Fritts,et al.  Viral RNA Levels and env Variants in Semen and Tissues of Mature Male Rhesus Macaques Infected with SIV by Penile Inoculation , 2013, PloS one.

[37]  T. Hope,et al.  Defining the Interaction of HIV-1 with the Mucosal Barriers of the Female Reproductive Tract , 2013, Journal of Virology.

[38]  Olivier Gascuel,et al.  Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner , 2013, PloS one.

[39]  A. Lackner,et al.  Monocyte/macrophages and their role in HIV neuropathogenesis , 2013, Immunological reviews.

[40]  E. L. Potter,et al.  Comparison of Viral Env Proteins from Acute and Chronic Infections with Subtype C Human Immunodeficiency Virus Type 1 Identifies Differences in Glycosylation and CCR5 Utilization and Suggests a New Strategy for Immunogen Design , 2013, Journal of Virology.

[41]  Feng Gao,et al.  Phenotypic properties of transmitted founder HIV-1 , 2013, Proceedings of the National Academy of Sciences.

[42]  J. Kublin,et al.  Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load? , 2013, AIDS.

[43]  S. Müller,et al.  Robust inducible Cre recombinase activity in the human malaria parasite Plasmodium falciparum enables efficient gene deletion within a single asexual erythrocytic growth cycle , 2013, Molecular microbiology.

[44]  Chaim A. Schramm,et al.  Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.

[45]  R. Doms,et al.  Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5 , 2012, Journal of Virology.

[46]  M. Vacher-Lavenu,et al.  The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages , 2012, Mucosal Immunology.

[47]  Oliver Laeyendecker,et al.  Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. , 2012, The Journal of infectious diseases.

[48]  Lynn Morris,et al.  Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape , 2012, Nature Medicine.

[49]  P. Hraber,et al.  HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection , 2012, Retrovirology.

[50]  Gianguido C. Cianci,et al.  Human cervicovaginal mucus contains an activity that hinders HIV-1 movement , 2012, Mucosal Immunology.

[51]  A. Samri,et al.  Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection , 2012, PloS one.

[52]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[53]  Alan S. Perelson,et al.  Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape , 2012, PLoS pathogens.

[54]  H. Ding,et al.  Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7 , 2012, PLoS pathogens.

[55]  R. Swanstrom,et al.  The HIV-1 Env Protein: A Coat of Many Colors , 2012, Current HIV/AIDS Reports.

[56]  H. Ding,et al.  Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages , 2011, Journal of Virology.

[57]  K. Metzner,et al.  Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  R. Kaul,et al.  Characterization of a Human Cervical CD4+ T Cell Subset Coexpressing Multiple Markers of HIV Susceptibility , 2011, The Journal of Immunology.

[59]  Cassandra B. Jabara,et al.  Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID , 2011, Proceedings of the National Academy of Sciences.

[60]  Yan Liu,et al.  A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield , 2011, Science.

[61]  Young Do Kwon,et al.  Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 , 2011, Nature.

[62]  R. Kaul,et al.  Foreskin T cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile and memory status , 2011, Mucosal Immunology.

[63]  Tanmoy Bhattacharya,et al.  Role of donor genital tract HIV-1 diversity in the transmission bottleneck , 2011, Proceedings of the National Academy of Sciences.

[64]  M. McElrath,et al.  Vaginal Langerhans Cells Nonproductively Transporting HIV-1 Mediate Infection of T Cells , 2011, Journal of Virology.

[65]  Pham Phung,et al.  Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.

[66]  Feng Gao,et al.  Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections , 2011, PLoS pathogens.

[67]  A. Perelson,et al.  A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity , 2011, PloS one.

[68]  J. Sodroski,et al.  Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins , 2011, Journal of Virology.

[69]  J. Brenchley,et al.  Low levels of SIV infection in sooty mangabey central-memory CD4+ T-cells is associated with limited CCR5 expression , 2011, Nature Medicine.

[70]  D. Montefiori,et al.  The Genetic Bottleneck in Vertical Transmission of Subtype C HIV-1 Is Not Driven by Selection of Especially Neutralization-Resistant Virus from the Maternal Viral Population , 2011, Journal of Virology.

[71]  E. Bunnik,et al.  Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies , 2011, Journal of Virology.

[72]  L. Morris,et al.  The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection , 2011, Journal of Virology.

[73]  G. Vanham,et al.  HIV sexual transmission and microbicides , 2011, Reviews in medical virology.

[74]  J. Pudney,et al.  HIV Infection and Immune Defense of the Penis , 2011, American journal of reproductive immunology.

[75]  J. Pudney,et al.  HIV infection of the penis , 2011 .

[76]  B. Korber,et al.  Genital Tract Sequestration of SIV following Acute Infection , 2011, PLoS pathogens.

[77]  A. Fauci,et al.  The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7 +/CD4+ T cells As Key Targets in Mucosal Transmission , 2011, PLoS pathogens.

[78]  J. Grivel,et al.  Selective transmission of R5 HIV-1 variants: where is the gatekeeper? , 2011, Journal of Translational Medicine.

[79]  K. Reimann,et al.  Blocking of α4β7 Gut-Homing Integrin during Acute Infection Leads to Decreased Plasma and Gastrointestinal Tissue Viral Loads in Simian Immunodeficiency Virus-Infected Rhesus Macaques , 2011, The Journal of Immunology.

[80]  A. Haase,et al.  Early events in sexual transmission of HIV and SIV and opportunities for interventions. , 2011, Annual review of medicine.

[81]  G. Gottlieb,et al.  HIV-1 Envelope Subregion Length Variation during Disease Progression , 2010, PLoS pathogens.

[82]  O. Pybus,et al.  B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection , 2010, Nature communications.

[83]  F. Hecht,et al.  The detection of acute HIV infection. , 2010, The Journal of infectious diseases.

[84]  J. Mullins,et al.  Comment on "The Origins of Sexually Transmitted HIV Among Men Who Have Sex with Men" , 2010, Science Translational Medicine.

[85]  E. Bunnik,et al.  Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level , 2010, Nature Medicine.

[86]  Cassandra B. Jabara,et al.  HIV-1 Populations in Semen Arise through Multiple Mechanisms , 2010, PLoS pathogens.

[87]  Bradley C. Lowekamp,et al.  3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells , 2010, Proceedings of the National Academy of Sciences.

[88]  R. Swanstrom,et al.  A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia. , 2010, The Journal of infectious diseases.

[89]  S. Moses,et al.  Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. , 2010, The American journal of pathology.

[90]  Alan S. Perelson,et al.  High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men , 2010, PLoS pathogens.

[91]  D. Montefiori,et al.  Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. , 2010, Blood.

[92]  Hui Li,et al.  Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users , 2010, Journal of Virology.

[93]  E. Bunnik,et al.  Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. , 2010, The Journal of infectious diseases.

[94]  T. Hope,et al.  Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation , 2010, PLoS pathogens.

[95]  B. Korber,et al.  Autologous Neutralizing Antibodies to the Transmitted/Founder Viruses Emerge Late after Simian Immunodeficiency Virus SIVmac251 Infection of Rhesus Monkeys , 2010, Journal of Virology.

[96]  Tanzy M. T. Love,et al.  Mathematical Modeling of Ultradeep Sequencing Data Reveals that Acute CD8+ T-Lymphocyte Responses Exert Strong Selective Pressure in Simian Immunodeficiency Virus-Infected Macaques but Still Fail To Clear Founder Epitope Sequences , 2010, Journal of Virology.

[97]  Ashley T. Haase,et al.  Targeting early infection to prevent HIV-1 mucosal transmission , 2010, Nature.

[98]  J. Mulenga,et al.  Donor and Recipient Envs from Heterosexual Human Immunodeficiency Virus Subtype C Transmission Pairs Require High Receptor Levels for Entry , 2010, Journal of Virology.

[99]  Sergei L. Kosakovsky Pond,et al.  The Origins of Sexually Transmitted HIV Among Men Who Have Sex with Men , 2010, Science Translational Medicine.

[100]  N. Dejucq-Rainsford,et al.  HIV infection of the male genital tract – consequences for sexual transmission and reproduction , 2010, International journal of andrology.

[101]  R. Kaul,et al.  The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1 , 2009, Proceedings of the National Academy of Sciences.

[102]  Holly Janes,et al.  Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.

[103]  Pham Phung,et al.  Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.

[104]  G. Learn,et al.  Compartmentalization of HIV-1 within the Female Genital Tract Is Due to Monotypic and Low-Diversity Variants Not Distinct Viral Populations , 2009, PloS one.

[105]  D. Montefiori,et al.  Effect of B-Cell Depletion on Viral Replication and Clinical Outcome of Simian Immunodeficiency Virus Infection in a Natural Host , 2009, Journal of Virology.

[106]  J. Baeten,et al.  Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression , 2009, Journal of Virology.

[107]  M. Sagar,et al.  Human Immunodeficiency Virus Type 1 V1-to-V5 Envelope Variants from the Chronic Phase of Infection Use CCR5 and Fuse More Efficiently than Those from Early after Infection , 2009, Journal of Virology.

[108]  S. Ratcliffe,et al.  Heterosexual Transmission of Human Immunodeficiency Virus Type 1 Subtype C: Macrophage Tropism, Alternative Coreceptor Use, and the Molecular Anatomy of CCR5 Utilization , 2009, Journal of Virology.

[109]  A. Perelson,et al.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection , 2009, The Journal of experimental medicine.

[110]  R. Speck,et al.  Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection , 2009, Seminars in Immunopathology.

[111]  Alan S. Perelson,et al.  Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1 , 2009, The Journal of experimental medicine.

[112]  A. Lackner,et al.  The gastrointestinal tract and AIDS pathogenesis. , 2009, Gastroenterology.

[113]  David Montefiori,et al.  Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain. , 2009, Blood.

[114]  S. Pambuccian,et al.  Glycerol monolaurate prevents mucosal SIV transmission , 2009, Nature.

[115]  G. Bobashev,et al.  High dead-space syringes and the risk of HIV and HCV infection among injecting drug users. , 2009, Drug and alcohol dependence.

[116]  Wei Huang,et al.  Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. , 2009, The Journal of infectious diseases.

[117]  R. Swanstrom,et al.  Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants , 2009, Journal of Virology.

[118]  Cynthia A. Derdeyn,et al.  Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1 , 2009, PLoS pathogens.

[119]  N. Rioux-Leclercq,et al.  Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo , 2008, Retrovirology.

[120]  W. Greene,et al.  The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus Infection , 2008, Journal of Virology.

[121]  B. Chohan,et al.  Human Immunodeficiency Virus Type 1 Superinfection Occurs despite Relatively Robust Neutralizing Antibody Responses , 2008, Journal of Virology.

[122]  Morgan A Reuter,et al.  HIV Traffics through a Specialized, Surface-Accessible Intracellular Compartment during trans-Infection of T Cells by Mature Dendritic Cells , 2008, PLoS pathogens.

[123]  E. Sanders-Buell,et al.  Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. , 2008, Virology.

[124]  Hanneke Schuitemaker,et al.  Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection , 2008, Journal of Virology.

[125]  M. McElrath,et al.  Setting the stage: host invasion by HIV , 2008, Nature Reviews Immunology.

[126]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[127]  J. Mullins,et al.  Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. , 2008, Virology.

[128]  D. Nickle,et al.  Male genital tract compartmentalization of human immunodeficiency virus type 1 (HIV). , 2008, AIDS research and human retroviruses.

[129]  P. Roques,et al.  Infection of Semen-Producing Organs by SIV during the Acute and Chronic Stages of the Disease , 2008, PloS one.

[130]  Eva Chung,et al.  HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells , 2008, Nature Immunology.

[131]  B. Korber,et al.  Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing , 2008, Journal of Virology.

[132]  P. Bieniasz,et al.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu , 2008, Nature.

[133]  D. Burton,et al.  Edinburgh Research Explorer Variation in HIV-I R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors , 2022 .

[134]  F. Kirchhoff,et al.  Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection , 2007, Cell.

[135]  F. Buonaguro,et al.  Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic Implications , 2007, Journal of Virology.

[136]  Hui Li,et al.  Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection , 2007, Journal of Virology.

[137]  Y. Kooyk,et al.  Langerin is a natural barrier to HIV-1 transmission by Langerhans cells , 2007, Nature Medicine.

[138]  Jun Li,et al.  Antiviral Antibodies Are Necessary for Control of Simian Immunodeficiency Virus Replication , 2007, Journal of Virology.

[139]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[140]  J. Overbaugh,et al.  Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity , 2006, Journal of Virology.

[141]  T. Pfeiffer,et al.  Effects of signal peptide exchange on HIV‐1 glycoprotein expression and viral infectivity in mammalian cells , 2006, FEBS letters.

[142]  Xiping Wei,et al.  Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[143]  Robin Shattock,et al.  Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? , 2006, Nature Reviews Microbiology.

[144]  S. Moses,et al.  HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. , 2006, American journal of clinical pathology.

[145]  Yang Liu,et al.  Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[146]  A. Haase.  Perils at mucosal front lines for HIV and SIV and their hosts , 2005, Nature Reviews Immunology.

[147]  Eun-Young Kim,et al.  Propagation and Dissemination of Infection after Vaginal Transmission of Simian Immunodeficiency Virus , 2005, Journal of Virology.

[148]  Dorothy M. Lang,et al.  Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels , 2005, Journal of Virology.

[149]  Yang Liu,et al.  Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B , 2005, Journal of Virology.

[150]  O. Laeyendecker,et al.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. , 2005, The Journal of infectious diseases.

[151]  A. Lackner,et al.  Classic AIDS in a Sooty Mangabey after an 18-Year Natural Infection , 2004, Journal of Virology.

[152]  Christopher D Pilcher,et al.  Brief but efficient: acute HIV infection and the sexual transmission of HIV. , 2004, The Journal of infectious diseases.

[153]  Bette T. Korber,et al.  Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission , 2004, Science.

[154]  J. Baeten,et al.  Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population , 2004, AIDS.

[155]  B. Jégou,et al.  Viruses in semen and male genital tissues--consequences for the reproductive system and therapeutic perspectives. , 2004, Current pharmaceutical design.

[156]  A. Haase,et al.  Transmission, acute HIV-1 infection and the quest for strategies to prevent infection , 2003, Nature Medicine.

[157]  D. McDonald,et al.  Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions , 2003, Science.

[158]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[159]  D. Richman,et al.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[160]  D. Nguyen,et al.  Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages , 2003, European journal of immunology.

[161]  D. Montefiori,et al.  Effect of Humoral Immune Responses on Controlling Viremia during Primary Infection of Rhesus Monkeys with Simian Immunodeficiency Virus , 2003, Journal of Virology.

[162]  Simon C Watkins,et al.  Memory CD4+ T Cells Are the Earliest Detectable Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Cells in the Female Genital Mucosal Tissue during HIV-1 Transmission in an Organ Culture System , 2002, Journal of Virology.

[163]  J. Overbaugh,et al.  HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus. , 2002, AIDS research and human retroviruses.

[164]  Eric Delwart,et al.  Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection , 2002, AIDS.

[165]  C. Cheng‐Mayer,et al.  Mucosal Transmission and Induction of Simian AIDS by CCR5-Specific Simian/Human Immunodeficiency Virus SHIVSF162P3 , 2001, Journal of Virology.

[166]  C. Mackay,et al.  T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.

[167]  L. Kingsley,et al.  Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. , 2000, The Journal of infectious diseases.

[168]  P. Watts,et al.  Parameters of Human Immunodeficiency Virus Infection of Human Cervical Tissue and Inhibition by Vaginal Virucides , 2000, Journal of Virology.

[169]  E. Ebert,et al.  Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation , 2000, Current Biology.

[170]  C. Figdor,et al.  Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.

[171]  Douglas S Kwon,et al.  DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.

[172]  E. De Clercq,et al.  Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations. , 1999, Journal of Acquired Immune Deficiency Syndromes.

[173]  E. Vittinghoff,et al.  Per-contact risk of human immunodeficiency virus transmission between male sexual partners. , 1999, American journal of epidemiology.

[174]  K. Shimoya,et al.  Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. , 1999, Molecular human reproduction.

[175]  C. Cheng‐Mayer,et al.  Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. , 1999, Science.

[176]  D. Montefiori,et al.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.

[177]  D. Richman,et al.  Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. , 1998, AIDS Research and Human Retroviruses.

[178]  Myron S. Cohen,et al.  Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis , 1998, The Lancet.

[179]  R. Gaynor,et al.  Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kappaB activation. , 1998, The Journal of infectious diseases.

[180]  J. Krieger,et al.  Vasectomy and human immunodeficiency virus type 1 in semen. , 1998, The Journal of urology.

[181]  A. Collier,et al.  Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. , 1998, The Journal of infectious diseases.

[182]  B. Walker,et al.  Human Immunodeficiency Virus Type 1 Populations in Blood and Semen , 1998, Journal of Virology.

[183]  R. Byrn,et al.  HIV-1 in semen: an isolated virus reservoir , 1997, The Lancet.

[184]  D. Desmond,et al.  Evaluation of needle and syringe combinations. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[185]  T. Delea,et al.  The Causal Role for Genital Ulcer Disease as a Risk Factor for Transmission of Human Immunodeficiency Virus: An Application of the Bradford Hill Criteria , 1996, Sexually transmitted diseases.

[186]  D. Ho,et al.  Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission , 1996, Journal of virology.

[187]  F. Plummer,et al.  Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. , 1995, The Journal of infectious diseases.

[188]  B. Chohan,et al.  Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1 , 1995, Journal of virology.

[189]  W. Johnson,et al.  Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis , 1995, The Journal of experimental medicine.

[190]  J. Margolick,et al.  Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. , 1995, The Journal of infectious diseases.

[191]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[192]  Kees,et al.  Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. , 1994, The Journal of clinical investigation.

[193]  T. Yoshino,et al.  Distinct but overlapping epitopes are involved in alpha 4 beta 7-mediated adhesion to vascular cell adhesion molecule-1, mucosal addressin-1, fibronectin, and lymphocyte aggregation. , 1994, Journal of immunology.

[194]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[195]  R. Weinstein,et al.  In-Vitro Resistance to Zidovudine and Alpha-interferon in HIV-1 Isolates from Patients: Correlations with Treatment Duration and Response , 1992, Annals of Internal Medicine.

[196]  B. Korber,et al.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. , 1992, Science.

[197]  N. Garrett,et al.  Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[198]  S. Gianella,et al.  HIV Trafficking Between Blood and Semen During Early Untreated HIV Infection , 2017, Journal of acquired immune deficiency syndromes.

[199]  G. Shaw,et al.  HIV transmission. , 2012, Cold Spring Harbor perspectives in medicine.

[200]  Christopher J. Miller,et al.  Target cells in vaginal HIV transmission. , 2003, Microbes and infection.

[201]  K. Williams,et al.  Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. , 2002, Annual review of neuroscience.

[202]  J. Overbaugh,et al.  Gender differences in HIV-1 diversity at time of infection , 2000, Nature Medicine.